Xencor Reports First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to Xencor Reports First Quarter 2020 Financial Results

Xencor (XNCR) Tops Q1 EPS by 24c, Revenues Beat

May 7, 2020 4:02 PM EDT

Xencor (NASDAQ: XNCR) reported Q1 EPS of ($0.14), $0.24 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $32.39 million versus the consensus estimate of $15.06 million.

Xencors XmAb® technologies enable us, and our partners, to create antibodies and cytokines with enhanced properties and potential new mechanisms of therapeutic action. Today, our clinical-stage XmAb bispecific antibodies and cytokines include five wholly owned candidates, two being co-developed... More